Revvity
Justin Anderle is an experienced Global Business Manager currently overseeing the neonatal screening software business at Revvity since May 2023. Prior to this role, Justin accumulated extensive experience at PerkinElmer, Inc. from January 2005 to May 2023, where responsibilities included strategic oversight as Global Business Manager and Global Product Manager for neonatal software products, as well as key roles in product management and software integration. Justin began a career in public health with the Texas Department of State Health Services as Team Leader for the Newborn Screening Laboratory. Academic credentials include a BA in Microbiology from The University of Texas at Austin and a Master's in Information Systems/Management from the University of Phoenix.
This person is not in any offices
Revvity
8 followers
At Revvity, “impossible” is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. Learn more at www.revvity.com